Kazia Therapeutics-Spon ADRKZIA
13F holders, Q3 2024 (September 30)17holders +6
9new positions
3sold out
1famous investor
$0.43avg. 13F price*
At the end of Q3 2024, 17 institutions reported holding Kazia Therapeutics-Spon ADR (KZIA) in their 13F filings, up 6 from Q2 2024. 9 opened new positions and 3 sold out. The largest holders were MAI Capital Management ($586K), UBS Group AG ($107K) and Morgan Stanley ($95K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Kazia Therapeutics-Spon ADR
- CUSIP
- 48669G105
- Latest filing quarter
- Q3 2024
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 9 | $659K |
| Exits | 3 | $33K |
All 13F filers, Q2 2024 → Q3 2024: 1,882,907 shares bought and 144,323 shares sold, net +1,738,584 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 17 holders
| MAI Capital Management | 0.01% | New | 1,363,894 | $586K |
| UBS Group AG | 0.00% | Add +969.0% | 249,452 | $107K |
| Morgan Stanley | 0.00% | Add +9.5% | 220,261 | $95K |
| Citadel Advisors | 0.00% | Add +1224.5% | 60,476 | $26K |
| Jane Street Group, LLC | 0.00% | New | 46,110 | $20K |
| United Bank | 0.00% | New | 44,000 | $19K |
| JPMorgan Chase & Co. | 0.00% | Add +1260766.7% | 37,826 | $16K |
| Commonwealth Equity Services, LLC | 0.00% | New | 30,500 | $13K |
| Rhumbline Advisers | 0.00% | Add +57.9% | 27,806 | $12K |
| XTX Topco Ltd | 0.00% | New | 23,395 | $10K |
| Geode Capital Management, LLC | 0.00% | New | 14,784 | $6K |
| Traynor Capital Management, Inc. | 0.00% | New | 10,000 | $4K |
| Wells Fargo & Company | 0.00% | No change | 500 | $215 |
| Osaic Holdings, Inc. | 0.00% | New | 500 | $215 |
| Allworth Financial LP | 0.00% | No change | 87 | $38 |
| AdvisorNet Financial, Inc | 0.00% | No change | 5 | $2 |
| Simplex Trading, LLC | 0.00% | New | 505 | $0 |
"% of holder's portfolio" is KZIA's weight in each manager's 13F, not the share of Kazia Therapeutics-Spon ADR the manager owns.